发明名称 Polynucleotides encoding BSL2v2c2-Ig
摘要 The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.
申请公布号 US9399052(B2) 申请公布日期 2016.07.26
申请号 US201414177641 申请日期 2014.02.11
申请人 Bristol-Myers Squibb Company 发明人 Mikesell Glen Eugene;Shen Henry;Chang Han;Finger Joshua N.;Yang Guchen;Peach Robert James
分类号 C07H21/04;C07K14/705;A61K38/17;C07K16/28;C07K19/00;A61K39/395;A61K38/00;A61K39/00 主分类号 C07H21/04
代理机构 代理人 D'Amico Stephen C.
主权项 1. An isolated polynucleotide comprising a sequence selected from the group consisting of: (a) an isolated polynucleotide comprising nucleotides encoding amino acids 1 to 480 of SEQ ID NO:135; (b) an isolated polynucleotide comprising nucleotides encoding amino acids 2 to 480 of SEQ ID NO:135; and (c) an isolated polynucleotide comprising nucleotides encoding amino acids 29 to 480 of SEQ ID NO:135.
地址 Princeton NJ US